open access

Vol 22, No 4 (2015)
Original articles
Published online: 2015-08-28
Get Citation

Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy

Edoardo Gronda, Stefano Genovese, Luigi Padeletti, Francesco Cacciatore, Dino Franco Vitale, Renato Bragato, Lisa Innocenti, Concetta Schiano, Linda Sommese, Maria Rosaria De Pascale, Luca Genovese, Pasquale Abete, Francesco Donatelli, Claudio Napoli
DOI: 10.5603/CJ.a2015.0019
·
Pubmed: 26325259
·
Cardiol J 2015;22(4):459-466.

open access

Vol 22, No 4 (2015)
Original articles
Published online: 2015-08-28

Abstract

Background: The use of cardiac resynchronization therapy (CRT) and implantable cardioverter- defibrillator (ICD) for advanced heart failure (HF) is increasing. Renal dysfunction is a common condition in HF which is associated with a worse survival. The study aims at identifying in patients with advanced HF treated with CRT the effect of baseline glomerular filtration rate (GFR), GFR improvement and left ventricular ejection fraction (LVEF) change, after 6-months of CRT implant, on survival.

Methods: The study population consisted of 375 advanced HF patients who received a CRT between 1999 and 2009, of these 277 received also an ICD implant. Clinical characteristics (New York Heart Association [NYHA] functional class, ischemic vs. non-ischemic etiology, atrial fibrillation, diabetes, hypertension, LVEF, QRS duration and GFR were recorded. The use of common used drugs was evaluated. Cox proportional hazards analysis was calculated in order to evaluate variables associated to mortality.

Results: During a median follow-up of 43.0 months, 93 (24.8%) patients died. Patients deceased during the study had at baseline higher NYHA class and lower LVEF and GFR. In Cox regression analysis, GFR predicts long-term mortality (hazard ratio [HR] 0.983; 95% confidence interval [CI] 0.969–0.998; p = 0.023) independently from the effect of others covariates. In addition, a positive GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality (for each 10 mL/min of GFR improvement HR 0.86; 95% CI 0.75–0.99; p = 0.038).

Conclusions: GFR is a significant predictor of mortality in advanced HF patients who received CRT. A GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality.  

Abstract

Background: The use of cardiac resynchronization therapy (CRT) and implantable cardioverter- defibrillator (ICD) for advanced heart failure (HF) is increasing. Renal dysfunction is a common condition in HF which is associated with a worse survival. The study aims at identifying in patients with advanced HF treated with CRT the effect of baseline glomerular filtration rate (GFR), GFR improvement and left ventricular ejection fraction (LVEF) change, after 6-months of CRT implant, on survival.

Methods: The study population consisted of 375 advanced HF patients who received a CRT between 1999 and 2009, of these 277 received also an ICD implant. Clinical characteristics (New York Heart Association [NYHA] functional class, ischemic vs. non-ischemic etiology, atrial fibrillation, diabetes, hypertension, LVEF, QRS duration and GFR were recorded. The use of common used drugs was evaluated. Cox proportional hazards analysis was calculated in order to evaluate variables associated to mortality.

Results: During a median follow-up of 43.0 months, 93 (24.8%) patients died. Patients deceased during the study had at baseline higher NYHA class and lower LVEF and GFR. In Cox regression analysis, GFR predicts long-term mortality (hazard ratio [HR] 0.983; 95% confidence interval [CI] 0.969–0.998; p = 0.023) independently from the effect of others covariates. In addition, a positive GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality (for each 10 mL/min of GFR improvement HR 0.86; 95% CI 0.75–0.99; p = 0.038).

Conclusions: GFR is a significant predictor of mortality in advanced HF patients who received CRT. A GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality.  

Get Citation

Keywords

cardiac resynchronization therapy, heart failure, outcome, renal function

About this article
Title

Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy

Journal

Cardiology Journal

Issue

Vol 22, No 4 (2015)

Pages

459-466

Published online

2015-08-28

DOI

10.5603/CJ.a2015.0019

Pubmed

26325259

Bibliographic record

Cardiol J 2015;22(4):459-466.

Keywords

cardiac resynchronization therapy
heart failure
outcome
renal function

Authors

Edoardo Gronda
Stefano Genovese
Luigi Padeletti
Francesco Cacciatore
Dino Franco Vitale
Renato Bragato
Lisa Innocenti
Concetta Schiano
Linda Sommese
Maria Rosaria De Pascale
Luca Genovese
Pasquale Abete
Francesco Donatelli
Claudio Napoli

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl